赜灵生物递表港交所

Group 1 - Chengdu Yiling Biomedical Technology Co., Ltd. (referred to as "Yiling Bio") submitted its listing application to the Hong Kong Stock Exchange on January 13, with Jefferies and CICC as joint sponsors [1] - Yiling Bio is a late-stage clinical biotechnology company focused on integrating structural biology, artificial intelligence, and clinically relevant disease models to develop highly differentiated small molecule therapies with first-in-class or best-in-class potential [1]